Antiretroviral therapy coverage for PMTCT in Pre-demographic dividend

Pre-demographic dividend: Antiretroviral therapy coverage for PMTCT was 84.4% in 2024. ◆ Volatile

Latest (2024)
84.4%
Change on year
down 0.4%
Rank
9th
of 15 groups
All-time high
85.2%
in 2019
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Pre-demographic dividend, 2000–2024

0204060802000201220242000: 0 % of pregnant women living with HIV2001: 0.08 % of pregnant women living with HIV2002: 0.495 % of pregnant women living with HIV2003: 1.9 % of pregnant women living with HIV2004: 5.3 % of pregnant women living with HIV2005: 13.7 % of pregnant women living with HIV2006: 21.4 % of pregnant women living with HIV2007: 35.6 % of pregnant women living with HIV2008: 47.5 % of pregnant women living with HIV2009: 54.9 % of pregnant women living with HIV2010: 36.7 % of pregnant women living with HIV2011: 51.3 % of pregnant women living with HIV2012: 63.3 % of pregnant women living with HIV2013: 69 % of pregnant women living with HIV2014: 74.3 % of pregnant women living with HIV2015: 77.9 % of pregnant women living with HIV2016: 77.5 % of pregnant women living with HIV2017: 80.8 % of pregnant women living with HIV2018: 82.9 % of pregnant women living with HIV2019: 85.2 % of pregnant women living with HIV2020: 84 % of pregnant women living with HIV2021: 84.4 % of pregnant women living with HIV2022: 82.6 % of pregnant women living with HIV2023: 84.7 % of pregnant women living with HIV2024: 84.4 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Pre-demographic dividend recorded 84.4% for antiretroviral therapy coverage for pmtct in 2024.

That represents a change of down 0.4% on the previous year and up 13.6% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Pre-demographic dividend peaked at 85.2% in 2019 and was at its lowest, 0.0%, in 2000.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Pre-demographic dividend, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Pre-demographic dividend, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.1%
2002 0.5% +520.2%
2003 1.9% +291.6%
2004 5.3% +174.1%
2005 13.7% +158.6%
2006 21.4% +56.2%
2007 35.6% +66.0%
2008 47.5% +33.4%
2009 54.9% +15.5%
2010 36.7% -33.2%
2011 51.3% +39.7%
2012 63.3% +23.5%
2013 69.0% +9.0%
2014 74.3% +7.7%
2015 77.9% +4.8%
2016 77.5% -0.5%
2017 80.8% +4.3%
2018 82.9% +2.6%
2019 85.2% +2.8%
2020 84.0% -1.4%
2021 84.4% +0.4%
2022 82.6% -2.2%
2023 84.7% +2.6%
2024 84.4% -0.4%

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Pre-demographic dividend changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2002 +520.2% 0.1% 0.5%
2003 +291.6% 0.5% 1.9%
2004 +174.1% 1.9% 5.3%
2005 +158.6% 5.3% 13.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 18.1% 0.0% 54.9% 10
2010s 69.9% 36.7% 85.2% 10
2020s 84.0% 82.6% 84.7% 5

Countries ranked near Pre-demographic dividend

  1. 9 Bolivia 98.0% compare
  2. 9 South Africa 98.0% compare
  3. 9 Zambia 98.0% compare
  4. 12 Cambodia 97.0% compare
  5. 12 Namibia 97.0% compare
  6. 12 Thailand 97.0% compare

See the full ranking of 99 places →

More health data for Pre-demographic dividend

All data for Pre-demographic dividend →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Pre-demographic dividend?
Antiretroviral therapy coverage for pmtct in Pre-demographic dividend was 84.4% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Pre-demographic dividend?
The highest recorded value was 85.2% in 2019.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Pre-demographic dividend?
The lowest recorded value was 0.0% in 2000.
How does Pre-demographic dividend rank for antiretroviral therapy coverage for pmtct?
Pre-demographic dividend ranks 9th out of 15 groups with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Pre-demographic dividend?
Over the last ten years it is up 13.6%. The long-run trend across the full record is volatile.
Where does this Pre-demographic dividend data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Pre-demographic dividend. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/pre-demographic-dividend/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/pre-demographic-dividend/">Antiretroviral therapy coverage for PMTCT in Pre-demographic dividend</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).